Similar Search Results

Do employers discriminate less if vacancies are difficult to fill? Evidence from a field experiment

Baert, Stijn; Cockx, Bart; Gheyle, Niels; Vandamme, Cora - 2013

We empirically test the relationship between hiring discrimination and labour market tightness at the level of the occupation. To this end, we conduct a correspondence test in the youth labour market. In line with theoretical expectations, we find that, compared to natives, candidates with a...

Persistent link: https://www.econbiz.de/10010291494

Overeducation at the Start of the Career - Stepping Stone or Trap?

Baert, Stijn; Cockx, Bart; Verhaest, Dieter - 2012

This study investigates whether young unemployed graduates who accept a job below their level of education accelerate or delay the transition into a job that matches their level of education. We adopt the Timing of Events approach to identify this dynamic treatment effect using monthly calendar...

Persistent link: https://www.econbiz.de/10010282055

The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: Evidence from longitudinal, disease-level data

Lichtenberg, Frank; Pettersson, Billie - 2012

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Persistent link: https://www.econbiz.de/10010283600

The contribution of pharmaceutical innovation to longevity growth in Germany and France

Lichtenberg, Frank - 2010

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …

Persistent link: https://www.econbiz.de/10010270528

Response to Baker and Fugh-Berman's critique of my paper, Why has longevity increased more in some states than in others?

Lichtenberg, Frank - 2009

increased more in some states than in others?" One of the conclusions I drew from that study was that medical innovation …-Berman express deep skepticism about my study's conclusion that medical innovation has played a very important role in recent U …

Persistent link: https://www.econbiz.de/10010272883

Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010

Lichtenberg, Frank - 2015

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)- about 44% of the total increase in longevity -and … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

Persistent link: https://www.econbiz.de/10010480895